Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.
Medline Inc. (MDLN) reported trailing twelve months revenue of $0 as of March 2026.
Medline Inc. generated $0 in TTM net income, with quarterly EBITDA of $676.00M. The operating margin stands at 5.7%.
The spread between operating margin (5.7%) and net margin (3.3%) indicates tight cost control with minimal non-operating drag.
MDLN trades at a P/S of N/A. The price-to-book ratio of 3.0x reflects a moderate premium to book value.
The company generated $316.00M in free cash flow over the trailing twelve months, indicating strong cash generation ability. The balance sheet shows $39.01B in total assets with $12.49B in long-term debt against $11.27B in stockholders equity for a debt-to-equity ratio of 1.1. Data based on the most recent quarterly reports.
Quarterly standardized metrics.
Stock price and market valuation
Revenue and earnings growth across quarters
Assets, cash, debt, and leverage
Price multiples and return ratios
Operating efficiency and return metrics
Free cash flow, earnings quality, and capital allocation